John McCambridge
Keine laufenden Positionen mehr
Profil
John McCambridge has been Vice President of Sales and Marketing for ImaRx Therapeutics, Inc. since May, 2006.
Prior to that, he was President and Chief Operating Officer of MRI Medical from 1998 to 2006.
Previously, he was Senior Vice President of Sales and Marketing for Genzyme Tissue Repair, formerly BioSurface Technology, from 1987 to 1997.
He started his career in Health Care with American Hospital Supply Corp.
from 1974 to 1985, where he was Vice President of Midwest Area Manager.
Mr. McCambridge received his BS degree in Business Administration from the University of Delaware.
Ehemalige bekannte Positionen von John McCambridge
| Unternehmen | Position | Ende |
|---|---|---|
Genzyme Tissue Repair
 Genzyme Tissue Repair BiotechnologyHealth Technology Genzyme Tissue Repair develops biological products and devices for orthopedic injuries such as cartilage damage and severe burns. The company is headquartered in Cambridge, MA | Vertrieb & Marketing | 01.01.1997 |
| American Hospital Supply Corp. | Corporate Officer/Principal | 01.01.1985 |
KeraCure, Inc.
 KeraCure, Inc. Medical DistributorsDistribution Services KeraCure, Inc. develops and manufactures health care products. It improves natural regenerative process of the human body. The firm's products include the KeraPac a living tissue that stimulates the body’s own natural healing process by activating ability to repair and regenerate tissue The company was founded in 1999 by Riley S. Rees and is headquartered in Chicago, IL. | Direktor/Vorstandsmitglied | - |
ImaRx Therapeutics, Inc.
 ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Vertrieb & Marketing | - |
Ausbildung von John McCambridge
| University of Delaware | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
ImaRx Therapeutics, Inc.
ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Health Technology |
Genzyme Tissue Repair
Genzyme Tissue Repair BiotechnologyHealth Technology Genzyme Tissue Repair develops biological products and devices for orthopedic injuries such as cartilage damage and severe burns. The company is headquartered in Cambridge, MA | Health Technology |
| American Hospital Supply Corp. | Health Technology |
KeraCure, Inc.
KeraCure, Inc. Medical DistributorsDistribution Services KeraCure, Inc. develops and manufactures health care products. It improves natural regenerative process of the human body. The firm's products include the KeraPac a living tissue that stimulates the body’s own natural healing process by activating ability to repair and regenerate tissue The company was founded in 1999 by Riley S. Rees and is headquartered in Chicago, IL. | Distribution Services |
